Abstract
In recent years it has become increasingly clear that brain function and therefore behavior cannot be understood simply in terms of the “hard-wiring” circuitry in the nervous system. The integrative capacity of the nervous system must accrue from the enormous variability of the intercellular transmission process between neurons. Furthermore, it is now evident that not only is the transmission process of central neurons extraordinarily varied but so is the chemical vocabulary by which neurons communicate. There has been considerable recent evidence, primarily from histo-chemistry, release and uptake studies, that transmitter-like molecules may co-exist in certain vertebrate neurons (Osborne, 1981). However, the fact that a neuron contains several putative transmitter substances, does not establish that each substance is being released as a transmitter. It certainly is possible that some neurons release more than one type of transmitter substance from the same terminal wherein only one of these would serve as the primary neurotransmitter with the others functioning to modify or modulate the action of the primary neurotransmitter.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Albertson, T.E., Stark, L.G., Joy, R.M. and Bowyer, J.F. (1983). Exper. Neurol., 81, 703–713.
Albertson, T.E., Joy, R.M. and Stark, L.G. (1983). Pharm. Biochem. Behav., 19, 339–343.
Baird-Lambert, J., Marwood, J.F., Davies, L.P. and Taylor, K.M. (1980). Life Sciences, 26, 1069–1077.
Barraco, R.A., Coffin, V.L., ATtman, H.J. and Phillis, J.W. (1983). Brain Res., 272, 392–395.
Barraco, R.A., Swanson, T.H., Phillis, J.W. and Berman, R.F. (1984). Neurosci. Letts., 46, 317–322.
Barraco, R.A., Aggarwal, A.K., Phillis, J.W., Moron, M.A. and Wu, P.H. (1984). Neurosci. Letts., (in press).
Bruns, R.F., Daly, J.W. and Snyder, S.H. (1980). Proc. Natl. Acad. Sci. U.S.A., 77, 5541–5551.
Bruns, R.F., Katims, J.J., Annau, Z., Snyder, S.H. and Daly, J.W. (1983). Neuropharm., 22, 1523–1529.
Buday, D.V., Carr, C.J. andMiya, T.S. (1961). J. Pharm. Pharmacol., 13, 290–299.
Burnstock, G. (1978). In Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach. (eds. R.W. Straub and L. Bolis). Raven Press, New York, 107–118.
Caprogrossi, M.C., Francendese, A. and DiGirolamo, M. (1979). Am. J. Clin. Nutr., 32, 1762–1768.
Coffin, V.L. and Carney, J.M. (1983). In Physiology and Pharmacology of Adenosine Derivatives. (eds. J. Daly, Y. Kuroda, J. Phillis and M. Ui). Raven Press, New York, 267–274.
Coffin, V.L., Taylor, J.A., Phillis, J.W., Altman, H.J. and Barraco, R.A. (1984). Neurosci. Letts., (in press).
Collier, H.O.J., Plant, N.J., Tucker, J.F. and von Uexkull, A. (1984). Proceed. Brit. Pharmacol. Soc., Jan. 4th–6th, 79.
Crawley, J.N., Patel, J. and Marangos, P.J. (1981). Life Sciences, 29, 2623–2630.
Crawley, J.N., Patel, J. and Marangos, P.J. (1983). Neurosci. Letts., 36, 169–174.
Daly, J.W. (r379). In Physiological Regulatory Functions of Adenosine and Adenine Nucleotides. (eds. H.P. Baer and G.I. Drummond). Raven Press, New York, 229–242.
Daly, J.W. (1982). J. Medicinal Chem., 25, 197–207.
Dascombe, M.J. and Milton, A.S. (1975). J. Physiol. (Lond.), 250, 143–160.
Dunwiddie, T.V. and Worth, T. (1982). J. Pharmacol. Exp. Ther., 220, 70–76.
Feldberg, W. and Sherwood, S.L. (1954). J. Physiol. (Lond.), 123, 148–167.
Fredholm, B.B. (1982). Focus on Research. Med. Biol., 60, 289–293.
Fredholm, B.B. and Vernet, L. (1979). Acta Physiol. Scand., 106, 97–107.
Fredholm, B.B. and Hedqvist, P. (1980). Biochem. Pharmacol., 29, 1635–1643.
Fredholm, B.B., Herrera-Marschitz, M., Jonzon, B., Lindstrom, K. and Ungerstedt, U. (1983). Pharm. Biochem. Behav., 19, 535–541.
Haulica, I., Ababei, L., Branisteanu, Topoliceanu, F. (1973). J. Neurochem., 21, 1019–1020.
Hedner, T., Hedner, J., Wessberg, P. and Jonason, J. (1982). Neurosci. Letts., 33, 147–151.
Hollins, C. and Stone, TW. (1980). Br. J. Pharmacol., 69, 107–112.
Holmgren, M., Hedner, T., Nordberg, G. and Mellstrand, T. (1983). J. Pharm. Pharmacol., 35, 679–680.
Holtzman, S.G. (1983). LiTE Sciences, 33, 779–787.
Katims, J.J., Annau, Z. and Snyder, S.H. (1983). J. of Pharm. Exp. Therap., 227, 167–173.
Katims, J.J., Murphy,K.M.M. and Snyder, S.H. (1983). In Stimulants: Neurochemical, Behavioral and Clinical Perspectives. (ed. E. Creese). Raven Press, New York, 63–79.
Lagercrantz, H., Yamamoto, Y., Fredholm, B.B., Prabhakar, N.R. and von Euler, C. (1984). Pediatric Res., 18, 387–389.
Levine, A.S. and Morley, J.E. (1982). Science, 217, 77–79.
Levine, A.S. and Morley, J.E. (1983). Pharm. Biochem. Behav., 19, 23–26.
Lewin, E. (1976). Trans. Am. Neurol. Assoc., 101, 192–194.
Londos, C., Cooper, C.M.F. and Wolff, J. (1980). Proc. Natl. Acad. Sci. U.S.A., 77, 2551–2554.
Maitre, M., Ciesielski, 17, Lehmann, A., Kempl, E. and Mandel, P. (1974). Biochem. Pharmacol., 23, 2807–2816.
Major, P.P., Agarwal, R.P. and Kufe, D.W. (1981). Cancer Chemother. Pharmacol., 5, 193–196.
Mascherpa, P. von (1971). Arzneim. Forsch., 21, 25–26.
Mendelson, W.B., Kuravilla, A., Watlington, T.;Goehl, K., Paul, S.M. and Skolnick, P. (1983). Psychopharm., 79, 126–129.
Morley, E. and Nistico, G. (1972). Br. J. Pharmacol., 46, 619–636.
Osborne, N.N. (1981). Neurochem. Internat., 3, 3–20.
Paalzow, G. and Paalzow, L. (1973). Acta Pharmacol. et Toxicol., 32, 22–32.
Phillis, J.W. and Wu, P.H. (1981). Progr. Neurobiol., 16, 187–239.
Radulovacki, M., Miletich, R.S. and Green, R.D. (1982). Brain Res., 246, 178–180.
Radulovacki77., Virus, R.M., Djuricic-Nedelson, M. and Green, R.D. (1983). Brain Res., 271, 392–395.
Sattin, A. and Rall, T.W. (1970). Mol. Pharmacol., 6, 13–23.
Snyder, S.H., Katims, J.J., Annau, Z., Bruns, R.F. and Daly, J.W. (1981). Proc. Natl. Acad. Sci. U.S.A., 78, 3260–3264.
Solis-Cohen, S. and Githens, T.S. (1928). In Pharmacotherapeutics: Materia Medica and Drug Action. Appleton and Co., New York, 1683.
Spignoli, G., Pedata, F. and Pepeu, G. (1984). Europ. J. Pharmacol., 97, 341–342.
Thithapanda, A., H.M. and Gillette, J.R. (1972). Proc. Soc. Exp. Biol. Med., 139, 582–586.
Twente, J.W., Twente, J. and Giorgio, N.A. (1970). Comp. Gen. Pharmacol., 1, 485–491.
Valdez, J.J., McGuire, P.S. and Annau, Z. (1982). Psychopharm., 76, 325–328.
van CeTker, D., Muller, M. and Hamprecht, B. (1979). J. Neurochem., 33, 999–1005.
Vapaatalo, H., Ongin, D., Neuvonen, P.J. and Westermann, E. (1975). Arzneim. Forsch., 25, 407–410.
Virus, R.M., Djuricic-Nedelson, M., Radulovacki, M. and Green, R.D. (1983). Neuropharm., 22, 1401–1404.
Wachtel, H. (1983). J. Neural Transmiss., 56, 139–152.
Wager-Srdar, S.A., Oken, M.M., Morley, J.E. and Levine, A.S. (1983). Life Sciences, 33, 2431–2438.
Williams, M. (1984). Trendsin Neurosci., 7, 164–168.
Wu, P.H., Moron, M. and Barraco, R.A. (1984T. Neurochem. Res., 9, (in press). —
Yarbrough, G.G. and McGuffin-Clineschmidt, J.C. (1981). Europ. J. Pharmacol., 76, 137–144.
Editor information
Editors and Affiliations
Copyright information
© 1985 The Contributors
About this chapter
Cite this chapter
Barraco, R.A. (1985). Behavioral Actions of Adenosine Analogues. In: Stone, T.W. (eds) Purines. Satellite Symposia of the IUPHAR 9th International Congress of Pharmacology. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-07564-5_4
Download citation
DOI: https://doi.org/10.1007/978-1-349-07564-5_4
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-07566-9
Online ISBN: 978-1-349-07564-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)